• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处方药监测计划对海洛因治疗入院影响的时间序列分析

Time-Series Analysis of the Impact of Prescription Drug Monitoring Programs on Heroin Treatment Admissions.

作者信息

Branham Douglas Keith

机构信息

a University of Kentucky , Department of Health Management and Policy , Lexington , Kentucky , USA.

出版信息

Subst Use Misuse. 2018 Mar 21;53(4):694-701. doi: 10.1080/10826084.2017.1363232. Epub 2017 Sep 27.

DOI:10.1080/10826084.2017.1363232
PMID:28952830
Abstract

BACKGROUND

Prescription drug abuse has become a major issue in the United States in recent years. Prescription drug monitoring programs (PDMPs) are designed to help health care providers to prevent such abuses. There may be unintended effects of these programs. Specifically, PDMPs may move prescription opioid users to begin use of heroin.

OBJECTIVES

This article aims to evaluate the impact of PDMPs on heroin abuse across several different states through use of treatment admissions records obtained from the Treatment Episode Data Set.

METHODS

Operational dates and other characteristics of state PDMPs were obtained from the Prescription Drug Monitoring Program Training and Technical Assistance Center. Data for the dependent variable were collected from the Treatment Episodes Data Set from 1992 to 2012. Interrupted time-series analyses using autoregressive integrated moving average modeling were used to estimate the effect of presence of an operational PDMP on the number of admissions reporting heroin as their primary drug being used.

RESULTS

The relationship between heroin admissions and prescription opioid admissions was significant for the average data (β = 0.41, p = 0.0017) and the 5-year data (β = 0.5, p = 0.036), both showing positive associations between heroin and prescription drug admissions in states in the post PDMP implementation period. Conclusions/Importance: The study found a positive relationship that between heroin and prescription opioid admissions post PDMP implementation. Future research should attempt to identify what this relationship means and how this information can be used to improve opioid policy.

摘要

背景

近年来,处方药滥用已成为美国的一个主要问题。处方药监测计划(PDMPs)旨在帮助医疗保健提供者预防此类滥用行为。这些计划可能会产生意想不到的影响。具体而言,PDMPs可能会促使处方阿片类药物使用者开始使用海洛因。

目的

本文旨在通过使用从治疗事件数据集获得的治疗入院记录,评估PDMPs对几个不同州海洛因滥用的影响。

方法

从处方药监测计划培训和技术援助中心获取州PDMPs的运行日期和其他特征。因变量的数据从1992年至2012年的治疗事件数据集中收集。使用自回归积分移动平均模型进行中断时间序列分析,以估计运行中的PDMPs对报告使用海洛因为主要药物的入院人数的影响。

结果

海洛因入院人数与处方阿片类药物入院人数之间的关系在平均数据(β = 0.41,p = 0.0017)和5年数据(β = 0.5,p = 0.036)中均具有显著性,两者均显示在PDMPs实施后各州海洛因与处方药入院人数之间存在正相关。结论/重要性:该研究发现PDMPs实施后海洛因与处方阿片类药物入院人数之间存在正相关关系。未来的研究应试图确定这种关系意味着什么,以及如何利用这些信息来改善阿片类药物政策。

相似文献

1
Time-Series Analysis of the Impact of Prescription Drug Monitoring Programs on Heroin Treatment Admissions.处方药监测计划对海洛因治疗入院影响的时间序列分析
Subst Use Misuse. 2018 Mar 21;53(4):694-701. doi: 10.1080/10826084.2017.1363232. Epub 2017 Sep 27.
2
Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.处方药监测项目、处方药的非医疗使用及海洛因使用:来自全国药物使用和健康调查的证据
Addict Behav. 2017 Jun;69:65-77. doi: 10.1016/j.addbeh.2017.01.011. Epub 2017 Jan 6.
3
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.处方药物监测项目的运行特征与致命海洛因中毒。
Int J Drug Policy. 2019 Dec;74:174-180. doi: 10.1016/j.drugpo.2019.10.001. Epub 2019 Oct 15.
4
Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.10 个美国州的医疗保险受益人中处方药物监测计划(PDMP)对阿片类药物使用的影响。
Addiction. 2017 Oct;112(10):1784-1796. doi: 10.1111/add.13860. Epub 2017 Jun 27.
5
Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.州级处方药物监测计划(PDMP)要求与医生为非癌症慢性疼痛患者开具阿片类镇痛药处方模式之间的关联。
Addict Behav. 2018 Jan;76:348-354. doi: 10.1016/j.addbeh.2017.08.032. Epub 2017 Sep 5.
6
Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).医生对马里兰州处方药监测计划(PDMP)的态度和经历。
Addiction. 2017 Feb;112(2):311-319. doi: 10.1111/add.13620. Epub 2016 Nov 3.
7
Do prescription drug monitoring programs encourage prescription - or illicit - opioid abuse?处方药监测项目会助长处方类或非法类阿片类药物的滥用吗?
Subst Abus. 2021;42(1):65-75. doi: 10.1080/08897077.2019.1695707. Epub 2019 Dec 10.
8
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse.强制性访问处方药物监测计划与处方药物滥用
J Policy Anal Manage. 2019;38(1):181-209.
9
A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.处方药物监测项目的分类:对 1999 年至 2016 年项目演变的潜在转移分析。
Addiction. 2019 Feb;114(2):248-258. doi: 10.1111/add.14440. Epub 2018 Oct 22.
10
Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences.必须访问的处方药物监测计划与阿片类药物过量流行:意料之外的后果。
J Health Econ. 2021 Jan;75:102408. doi: 10.1016/j.jhealeco.2020.102408. Epub 2020 Nov 26.

引用本文的文献

1
The Impact of Opioid Prescribing Limits on Drug Usage in South Carolina: A Novel Geospatial and Time Series Data Analysis.阿片类药物处方限制对南卡罗来纳州药物使用的影响:一项新型地理空间和时间序列数据分析
Healthcare (Basel). 2023 Apr 14;11(8):1132. doi: 10.3390/healthcare11081132.
2
Trends in Opioid Prescribing Following Pennsylvania Statewide Implementation of a Prescription Drug Monitoring Program.宾夕法尼亚州全州实施处方药监测计划后阿片类药物处方趋势
Cureus. 2022 Aug 11;14(8):e27879. doi: 10.7759/cureus.27879. eCollection 2022 Aug.
3
A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.
2014 - 2018年美国和加拿大系统层面政策与干预措施对与阿片类药物流行相关的人群层面结果影响的快速回顾
Public Health Rep. 2020 Jul/Aug;135(1_suppl):100S-127S. doi: 10.1177/0033354920922975.
4
The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.州级阿片类药物滥用预防政策与患者和医疗服务提供者相关结局的关联:范围综述。
Milbank Q. 2020 Mar;98(1):57-105. doi: 10.1111/1468-0009.12436. Epub 2019 Dec 4.
5
The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.处方药物监测项目在减少阿片类药物相关危害和后果方面的有效性:系统评价。
BMC Health Serv Res. 2019 Nov 1;19(1):784. doi: 10.1186/s12913-019-4642-8.
6
Systematic Literature Review of Prescription Drug Monitoring Programs.处方药监测项目的系统文献综述
AMIA Annu Symp Proc. 2018 Dec 5;2018:1478-1487. eCollection 2018.
7
Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border.墨西哥的阿片类药物使用泛滥问题出在哪里?对美国-墨西哥边境以南的政策制定者的一个警示故事。
Am J Public Health. 2019 Jan;109(1):73-82. doi: 10.2105/AJPH.2018.304767. Epub 2018 Nov 29.